Get started
Author

Patricia Muñoz-Garrido

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
2020 · Aitor Esparza-Baquer, Ibone Labiano, et al. · Gut · 126
PDF
MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation
2017 · Oihane Erice, Patricia Munoz‐Garrido, et al. · Hepatology · 95
PDF
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression
2017 · O. Erice, I. Labiano, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 80
Post-translational Regulation of the Type III Inositol 1,4,5-Trisphosphate Receptor by miRNA-506
2014 · Meenakshisundaram Ananthanarayanan, Jesus M. Banales, et al. · Journal of Biological Chemistry · 77
PDF
Soluble Adenylyl Cyclase Regulates Bile Salt‐Induced Apoptosis in Human Cholangiocytes
2016 · Jung‐Chin Chang, Simei Go, et al. · Hepatology · 70
PDF
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease
2015 · Patricia Munoz-Garrido, José J.G. Marin, et al. · Journal of Hepatology · 66
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
2020 · José J. G. Marin, Maria Giuseppina Prete, et al. · British Journal of Cancer · 59
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases
2014 · Aura D Urribarri, Patricia Munoz-Garrido, et al. · Gut · 59
Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy
2019 · Elisa Lozano, Rocio I.R. Macias, et al. · Hepatology · 54
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
2019 · Ivan Guerra, Luis Bujanda, et al. · Journal of Crohn s and Colitis · 53
Epigenome dysregulation in cholangiocarcinoma
2017 · Colm J. O'Rourke, Patricia Munoz-Garrido, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 48
PDF
The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma
2021 · Margherita Correnti, Andrea Cappon, et al. · Liver International · 42
PDF
Molecular Targets in Cholangiocarcinoma
2020 · Colm J. O’Rourke, Patricia Munoz‐Garrido, et al. · Hepatology · 40
MicroRNAs in biliary diseases
2012 · Patricia Munoz-Garrido · World Journal of Gastroenterology · 31
PDF
MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells
2022 · Lea Duwe, Patricia Munoz-Garrido, et al. · Journal of Hepatology · 26
PDF
Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer
2022 · Dan Høgdall, Colm J. O’Rourke, et al. · Journal of Hepatology · 26
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets
2020 · Alvaro Santos‐Laso, Laura Izquierdo‐Sanchez, et al. · Liver International · 25
The jigsaw of dual hepatocellular–intrahepatic cholangiocarcinoma tumours
2019 · Patricia Munoz-Garrido, Pedro M. Rodrigues · Nature Reviews Gastroenterology & Hepatology · 21
New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets
2017 · Alvaro Santos-Laso, Patricia Munoz-Garrido, et al. · Current Drug Targets · 13
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease
2020 · Francisco J. Caballero‐Camino, Ivan Rivilla, et al. · Hepatology · 12
PDF
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer
2021 · José J. G. Marin, Maria Giuseppina Prete, et al. · British Journal of Cancer · 4
PDF
Genetic Optimization of Liver Cancer Therapy: A Patient-Derived Primary Cancer Cell-Based Model
2016 · Patricia Munoz-Garrido, Jesper B. Andersen · Gastroenterology · 4
MicroRNAs in Liver Diseases
2013 · Patricia Munoz‐Garrido, Marco Marzioni, et al. · 3
The protease-inhibitor serpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma
2021 · M. Correnti, A. Cappon, et al. · Digestive and Liver Disease · 2
Contributors
2019 · E. Abou Diwan, Jesper B. Andersen, et al. · Elsevier eBooks · 1
Works count: 33
Citation count: 1,036
H-index: 18
I10-index: 20
Year
Topic
Type